These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3135775)

  • 1. Virulence of Brucella: bacterial growth and decline in mice.
    Plommet M; Plommet AM
    Ann Rech Vet; 1988; 19(1):65-7. PubMed ID: 3135775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of a residual Brucella abortus 19 vaccine infection in mice by a virulent challenge or by injection of brucellin or of Brucella lipopolysaccharide.
    Plommet M; Plommet AM
    Ann Rech Vet; 1988; 19(4):245-51. PubMed ID: 3148291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and immune responses after Brucella abortus infection in young adult and aged mice.
    High KP; Prasad R; Marion CR; Schurig GG; Boyle SM; Sriranganathan N
    Biogerontology; 2007 Oct; 8(5):583-93. PubMed ID: 17653832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
    Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
    Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Brucella cell-mediated immunity in mice vaccinated with a cell-wall fraction.
    Plommet M; Plommet AM
    Ann Rech Vet; 1987; 18(4):429-37. PubMed ID: 3451687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
    Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
    Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a splenic infection in mice of 4 strains, inoculated by the venous route, with 3 doses of Brucella abortus].
    Plommet M; Plommet AM
    Ann Rech Vet; 1982; 12(4):345-51. PubMed ID: 6814335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of integrase/recombinase xerD and monofunctional biosynthesis peptidoglycan transglycosylase genes in the pathogenicity of Brucella abortus infection in vitro and in vivo.
    Canavessi AM; Harms J; de Leon Gatti N; Splitter GA
    Microb Pathog; 2004 Nov; 37(5):241-51. PubMed ID: 15519045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.
    Delpino MV; Marchesini MI; Estein SM; Comerci DJ; Cassataro J; Fossati CA; Baldi PC
    Infect Immun; 2007 Jan; 75(1):299-305. PubMed ID: 17088355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines.
    Grilló MJ; Bosseray N; Blasco JM
    Biologicals; 2000 Jun; 28(2):119-27. PubMed ID: 10885618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.
    Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG
    Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice.
    Mukherjee F; Jain J; Grilló MJ; Blasco JM; Nair M
    Biologicals; 2005 Sep; 33(3):153-60. PubMed ID: 16081301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phagosome-lysosome fusion in macrophages by soluble extracts of virulent Brucella abortus.
    Frenchick PJ; Markham RJ; Cochrane AH
    Am J Vet Res; 1985 Feb; 46(2):332-5. PubMed ID: 3922258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages and Brucella.
    Baldwin CL; Winter AJ
    Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence.
    Manterola L; Guzmán-Verri C; Chaves-Olarte E; Barquero-Calvo E; de Miguel MJ; Moriyón I; Grilló MJ; López-Goñi I; Moreno E
    Infect Immun; 2007 Oct; 75(10):4867-74. PubMed ID: 17664262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of phosphatidylcholine, a typical eukaryotic phospholipid, is necessary for full virulence of the intracellular bacterial parasite Brucella abortus.
    Conde-Alvarez R; Grilló MJ; Salcedo SP; de Miguel MJ; Fugier E; Gorvel JP; Moriyón I; Iriarte M
    Cell Microbiol; 2006 Aug; 8(8):1322-35. PubMed ID: 16882035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucella abortus synthesizes phosphatidylcholine from choline provided by the host.
    Comerci DJ; Altabe S; de Mendoza D; Ugalde RA
    J Bacteriol; 2006 Mar; 188(5):1929-34. PubMed ID: 16484204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.